A giant MS plaque mimicking PML during natalizumab treatment

Journal of the Neurological Sciences

Volumn 291, Issue 1-2, 2010, Pages 110-113

  Twyman, Cary ^a   Berger, Joseph R ^b  

^a Associates in Neurology PSC   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Giant plaque; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; METHYLPREDNISOLONE; NATALIZUMAB; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFUSION; DIFFERENTIAL DIAGNOSIS; DYSARTHRIA; GAIT; HUMAN; JC VIRUS; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIODIAGNOSIS; RELAPSE; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; URINE INCONTINENCE;

ADULT; ANTIBODIES, MONOCLONAL; BRAIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOLOGIC FACTORS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS;

EID: 77349117963     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2010.01.001     Document Type: Article

References (12)

1. Benstetter, M. Meeting highlights from the Committee for Medicinal Products for Human Use, 19-22 October 2009. Press Release 2009 [cited 2009 October 24]; Available from: http://www.emea.europa.eu/pdfs/human/press/pr/67119009en.pdf.
2. Yousry T.A., Major E.O., Ryschkewitsch C., Fahle G., Fischer S., Hou J., et al. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354 9 (2006) 924-933
3. Berger J.R., and Houff S. Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab. Neurol Res 28 3 (2006) 299-305
4. Khatri B.O., Man S., Giovannoni G., Koo A.P., Lee J.C., Tucky B., et al. Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72 5 (2009) 402-409
5. Kepes J.J. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33 1 (1993) 18-27
6. Berger J.R., Pall L., Lanska D., and Whiteman M. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4 1 (1998) 59-68
7. Boster A., Hreha S., Berger J.R., Bao F., Penmesta R., Tselis A., et al. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol 66 5 (2009) 593-599
8. Brooks B.R., and Walker D.L. Progressive multifocal leukoencephalopathy. Neurol Clin 2 2 (1984) 299-313
9. Van Assche G., Van Ranst M., Sciot R., Dubois B., Vermeire S., Noman M., et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 353 4 (2005) 362-368
10. Weber T., Klapper P.E., Cleator G.M., Bodemer M., Luke W., Knowles W., et al., European Union Concerted Action on Viral Meningitis and Encephalitis. Polymerase chain reaction for detection of JC virus DNA in cerebrospinal fluid: a quality control study. J Virol Methods 69 1-2 (1997) 231-237
11. Cinque P., Koralnik I.J., and Clifford D.B. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol 9 Suppl 1 (2003) 88-92
12. Linda H., von Heijne A., Major E.O., Ryschkewitsch C., Berg J., Olsson T., et al. Progressive multifocal leukoencephalopathy after natalizumab monotherapy. N Engl J Med 361 11 (2009) 1081-1087